The 73% Success Rate: Clinical Evidence for Stem Cell ED Thera
Dr. Anya Sharra
Author
When it comes to medical treatments, data is the only thing that matters. At Nordic Stem Cell, we take pride in being the first clinic globally to offer an Erectile Dysfunction (ED) treatment backed by successful clinical trials.
The Landmark Study
Our research focused on a challenging group: men suffering from ED following prostate cancer surgery. Traditional treatments like pills or injections often fail this demographic because the underlying nerves and blood vessels are damaged.
Key Findings:
- High Success Rate: 73% of continent men in the trial regained spontaneous erectile function.
- Safety Profile: Zero serious adverse events were reported, as the body recognises its own autologous cells.
- Long-term Restoration: Unlike daily medication, the stem cells work to repair the damaged corporal tissue of the penis.
Why These Results Matter
These aren't just numbers; they represent a fundamental shift in men's health. By using your own adipose-derived regenerative cells, we are moving away from "managing" symptoms and toward "curing" the underlying biological cause.
Frequently Asked Questions
Find answers to common questions about this topic. Click on any question to reveal the answer.
In our clinical trials, 73% of men who were continent (had bladder control) after prostate surgery regained sufficient erectile function for intercourse following a single treatment.
Clinical follow-ups show sustained improvement at the 6-month and 12-month marks, as the therapy regenerates actual biological tissue rather than providing a temporary chemical boost.
Yes, our protocols and results are based on rigorous clinical standards and have been presented at major international urological conferences.